City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border 		  
  PROFILE 
The following is a list of available studies directed by  Yun Yen, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 09073
   P.I.: Yun Yen, MD (NCI Approved External Peer Review)
Title: PHI-64, NCI #8155; A Phase I Trial of Escalating Doses of the Anti-IGF-1R Monoclonal IMCA 12 and Standard Dose Sorafenib for Treatment of Advanced Hepatocellular Carcinoma
 
Click here for  Full Eligibility Criteria
 08243
   P.I.: Yun Yen, MD (Industrial)
Title: A Phase 1 Open Label/Phase 2 Randomized, Double-Blind, Multicenter Study Investigating the Combination of RAD001 and Sorafenib (Nexavar) in Patients with Advanced Hepatocellular Carcinoma
 
Click here for  Full Eligibility Criteria
 05127
   P.I.: Yun Yen, MD (Industrial)
Title: A Phase I Safety and Pharmacokinetic Study of IT-101 in the Treatment of Advanced Solid Tumors
 
Click here for  Full Eligibility Criteria
 

  
© 2009 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.